Martha Raymond, Founder and CEO of the GI Cancers Alliance and Raymond Foundation, shared on LinkedIn:
“ESMO – European Society for Medical Oncology 2026 in beautiful Madrid was a whirlwind of meetings, presentations and the opportunity to catch up with friends and colleagues.
Advances across gastrointestinal (GI) cancers offer reasons for optimism and important reminders about what meaningful progress requires. My question after ESMO is not only ‘What did we discover?’ but ‘How do we ensure these discoveries benefit patients globally?’ GI Cancers Alliance The Raymond Foundation, Amalya Sargsyan Knarik Arakelyan, Keith Kaplan.
Our GI Cancers Alliance blog shares ESMO GI research updates.”
You can also read: A Defining Moment for Cancer Immunotherapy During ESMO 2026 – Agenus
